Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
PZ HTL SA
GLOBETECH PUBLISHING LLC

Different Bacteria Cultures Maintained in Microfluidic System

By BiotechDaily International staff writers
Posted on 13 Aug 2013
Image: Microfluidic system for multiple bacterial cultures (Photo courtesy of Polish Institute of Physical Chemistry).
Image: Microfluidic system for multiple bacterial cultures (Photo courtesy of Polish Institute of Physical Chemistry).
A fabricated microfluidic device allows hundreds of different bacteria cultures to be maintained simultaneously.

The system allows for the merging, transporting and splitting of microdroplets where strictly controlled chemical reactions and the cultivation of bacterial colonies can be performed.

A group of scientists at the Institute of Physical Chemistry (Warsaw, Poland) engineered the microfluidic systems from polymer plates that correspond to the size of a credit card. Inside the system, a carrier fluid, mostly oil, carries microdroplets containing chemicals, flows laminarly through tiny channels of diameters in the range of tenths or hundredths of a millimeter. In this single microfluidic system thousands of different chemical reactions can be carried out during a day.

The microsystem is composed of two branches of microchannels forming densely arranged zigzags. A few hundred droplets can circulate in the microchannels, at a distance of about one centimeter from each other. The microdroplets move in a pendular movement from one branch to the other. Each droplet circulating within the microfluidic system has its own unique identifier, assigned by the optoelectronic system. It allows the scientist to monitor at any time what operations have been carried out on each microdroplet. A single droplet can include over 100,000 bacteria that are unable to move between the droplets, as the bacteria cannot cross the surface membrane of a microdroplet, and the carrier liquid used to transport microdroplets is not an environment favorable for the life of bacteria.

Piotr Garstecki, PhD, DSc, the lead author, said, “We can transform each microdroplet into a real bioreactor. Therefore, in a single small plate we can have up to several hundreds of bioreactors, with different, controlled concentration of an antibiotic, a different antibiotic or even different bacterial species in each bioreactor.” The paper was published on July 15, 2013, in the journal Angewandte Chemie International Edition.

Related Links:

Polish Institute of Physical Chemistry



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: This novel, flexible film that can react to light is a promising step toward an artificial retina (Photo courtesy of the American Chemical Society).

Novel Nanofilm May Be Artificial Retina Precursor

Researchers have used advanced nanotechnology techniques to develop a light-sensitive film that has potential for future artificial retina applications. Investigators at the Hebrew University of Jerusalem... Read more

Drug Discovery

view channel
Image: Disruption and removal of malaria parasites by the experimental drug (+)-SJ733 (Photo courtesy of the University of California, San Francisco).

Experimental Antimalaria Drug Induces the Immune System to Destroy Infected Red Blood Cells

An experimental drug for the treatment of malaria was found to induce morphological changes in infected erythrocytes that enabled the immune system to recognize and eliminate them. Investigators at... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Business

view channel

R&D Partnership Initiated to Reduce Development Time for New Drugs

nanoPET Pharma, GmbH (Berlin, Germany) signed an open-ended framework contract with the international pharmaceutical company Boehringer Ingelheim (Ridgefield, CT, USA). By developing customized contrast agents for research in both basic and preclinical studies, nanoPET Pharma will contribute to the enhancement of Boehringer... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.